As of 2026-04-25, the Intrinsic Value of Resmed Inc (RMD) is 291.95 USD. This Resmed valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 219.85 USD, the upside of Resmed Inc is 32.80%.
The range of the Intrinsic Value is 200.96 - 572.04 USD
Based on its market price of 219.85 USD and our intrinsic valuation, Resmed Inc (RMD) is undervalued by 32.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 200.96 - 572.04 | 291.95 | 32.8% |
| DCF (Growth 10y) | 249.16 - 677.63 | 355.06 | 61.5% |
| DCF (EBITDA 5y) | 239.33 - 318.38 | 276.99 | 26.0% |
| DCF (EBITDA 10y) | 283.80 - 400.82 | 337.34 | 53.4% |
| Fair Value | 217.63 - 217.63 | 217.63 | -1.01% |
| P/E | 293.42 - 473.67 | 349.80 | 59.1% |
| EV/EBITDA | 191.80 - 293.51 | 235.90 | 7.3% |
| EPV | 90.42 - 121.69 | 106.06 | -51.8% |
| DDM - Stable | 101.82 - 397.31 | 249.56 | 13.5% |
| DDM - Multi | 162.79 - 487.21 | 243.26 | 10.6% |
| Market Cap (mil) | 32,027.75 |
| Beta | 0.80 |
| Outstanding shares (mil) | 145.68 |
| Enterprise Value (mil) | 31,274.51 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.66% |
| Cost of Debt | 4.34% |
| WACC | 8.56% |